Aliaxin® LV
Aliaxin
Medical aesthetic productDermal filler \u2014 hyaluronic acid (lip volume)
Certifications
- CE Marked Class III medical device for professional use.
- CE Marked Class III medical device for professional use.
Dermal filler \u2014 hyaluronic acid (lip volume)
Description
Aliaxin® LV Lips Volume is a resorbable, sterile, non-pyrogenic, physiological hyaluronic acid gel filler specifically developed for lip volumisation and contouring, and for correction of medium and deep facial skin sagging. Based on cross-linked, non-animal HA produced by biofermentation, it provides harmonious and natural lip volume, restores firmness and definition, and treats common facial imperfections such as nasolabial folds and perioral wrinkles. The ready-to-use monophasic gel shows high tissue integration and stability, offering long-lasting, natural-looking results.
Bnefits
- Designed specifically for harmonious increase of lip volume and improved lip contour.
- Restores lip firmness while maintaining a natural look and feel.
- Treats medium and deep facial wrinkles and sagging (e.g. nasolabial folds, glabellar and frontal lines).
- Provides high tissue integration and stability for smooth, natural results and prolonged effect.
- Ultrapure, non-animal hyaluronic acid produced by patented biofermentation with low BDDE residue and low cross-linking percentage.
- Monophasic gel, ready to use without additional handling, optimised viscoelastic properties for flow, lift and sculpting.
- Temporary, fully resorbable filler with typical duration of 6–12 months depending on patient and treatment.
Indications
- Lip volumisation and contour enhancement.
- Restoration of physiological facial volumes.
- Correction of medium and deep sagging skin of the face.
- Nasolabial folds.
- Circumoral/perioral wrinkles.
- Glabellar wrinkles.
- Frontal (forehead) wrinkles.
- Facial and acne scars.
- Areas requiring enrichment of facial tissue (cheeks, chin, cheekbones, lips) with temporary volume increase.
Composition
- Cross-linked hyaluronic acid (non-animal origin) 25 mg/ml.
- Natural (non-cross-linked) hyaluronic acid 2.5 mg/ml.
- Molecular weight fractions: 1000 kDa and 2000 kDa.
- Phosphate buffer.
- Water for injectable solutions.
- Cross-linking agent: BDDE, low percentage cross-linking (<10%) and low BDDE residue (<0.1 ppm).
Formulation
- Monophasic, sterile, non-pyrogenic, physiological HA gel.
- Ready-to-use pre-filled syringes; no fragmentation or extra handling required.
- Rheological profile: Flow 0.53, Lift 39 Pa, Sculpt 0.28.
- Hydroaction 2/4 and Liftaction 4/5 for combined hydration and lifting performance.
Packaging
- Total volume: 2 ml (2 × 1 ml pre-filled disposable sterile syringes).
- 2 sealed blister packs, each containing one single-dose sterile syringe of 1 ml.
- 4 single-use sterile needles: 27G × 13 mm (½") and 27G × 19 mm (¾").
- Instruction leaflet (notice).
- Adhesive labels for patient file and product traceability.
Usage
- Use exclusively by qualified medical personnel experienced in dermal filler injections.
- Check integrity of packaging and expiry date; do not use if damaged or expired.
- Disinfect treatment area and maintain strict aseptic technique.
- Inject into the skin tissue (mid to deep dermis and/or lip tissue) for extracellular matrix supplementation and intracutaneous volumetric increase.
- Select injection technique (e.g. linear threading, serial puncture, fanning) according to indication and treatment plan.
- Adjust injected volume according to degree of correction required and specific treatment area, avoiding overcorrection.
- After injection, gently massage treated area if needed to ensure even gel distribution.
- Provide post-treatment advice, including avoiding intense heat/cold, vigorous exercise and manipulation of the lips or treated area for a short period.
- Single-use device: discard any unused product, syringes and needles as clinical waste.
Contraindications
- Hypersensitivity to hyaluronic acid or any component of the product.
- Active skin infection, inflammation or lesions near the intended injection site.
- Patients with a history of severe allergies or anaphylactic reactions.
- Pregnancy and breastfeeding (use not recommended).
- Severe autoimmune or immune system disorders (at physician’s discretion).
- Individuals under 18 years of age.
Adverse Effects
- Temporary redness (erythema), swelling, tenderness or pain at the injection site.
- Bruising or hematoma.
- Itching or transient discolouration.
- Palpable nodules or lumps, usually transient.
- Rare complications such as infection, granuloma formation, vascular occlusion or necrosis if injected intravascularly.
- Hypersensitivity or allergic reactions in susceptible patients.
Storage Conditions
- Store at 2–25°C (or 2–28°C as per packaging).
- Do not freeze.
- Keep in original packaging and protect from light.
- Do not use after the expiry date indicated on the pack.
Duration
Typically 6\u201312 months, depending on treated area, degree of correction, patient age, skin type and lifestyle.
Onset
Immediate
| Price | Link |
|---|---|
| £189.98 | https://dermafillerltd.uk/product/aliaxin-lv-2-x-1ml/ |
